12-Month Lobbying Summary - In-house Corporation

Gilead Sciences Canada / Paul Petrelli, General Manager

Registration Summary

Active - Last Updated: 2024-11-07

Who is lobbying?

Gilead Sciences Canada (Address & business activities)

Paul Petrelli, General Manager

Responsible officer in previous versions
- Christophe Griolet, V.P. and General Manager
- Scott Spencer, Executive Director, Finance - Interim General Manager

Received government funding or funding expected in current financial year

Business Relationships

Gilead Sciences Canada is a subsidiary of the following parent companies

Gilead Sciences Inc (Address information)

Beneficiaries of the Lobbying Activity

Gilead Sciences Canada does not have any subsidiaries that could have a direct interest in the outcome of the undertaking

What is being lobbied?

Subject Matter Details

Details Regarding the Identified Subject Matter
Subject matters	Details	Categories
Health, Science and Technology	Canada Agency for Drugs and Technologies in Health (CADTH) as it relates to health economics assessment and recommendations made on new medicines.	Policies or Program
Aboriginal Affairs, Health	Federal Government First Nations and Inuit Health Branch program with respect to health services. Federally-funded Public Drug Plans, with respect to reimbursement for drug products for federal plan beneficiaries.	Policies or Program
Economic Development, Employment and Training, Health, Industry, Intellectual Property, Research and Development, Science and Technology	Innovation Agenda, particularly with respect to initiatives to support and attract investments in the life sciences sector	Policies or Program
Health, Industry, Intellectual Property, International Trade, Research and Development, Science and Technology	Patent Act Regulations as they relate to the regulation of intellectual property for therapeutic products, specifically the Patented Medicines (Notice of Compliance) Regulations Patented Medicine Prices Review Board (PMPRB) Regulations with regard to reporting requirements, pricing, guidelines and dispute resolution.	Legislative Proposal, Bill or Resolution, Regulation
Aboriginal Affairs, Health, Immigration, Industry, Research and Development, Science and Technology	Policy and Programs Health Canada and Public Health Agency of Canada policies and programs to prevent and treat HIV and eliminate hepatitis as a public health threat by 2030, as part of Canada's commitments under the Global Viral Hepatitis Strategy and therapeutic efforts against the fight for COVID-19.	Policies or Program

Who is being lobbied?

Government Institutions

Canadian Institutes of Health Research (CIHR)
Correctional Service of Canada (CSC)
Finance Canada (FIN)
Global Affairs Canada (GAC)
Health Canada (HC)
House of Commons
Immigration, Refugees and Citizenship Canada (IRCC)
Indigenous Services Canada (ISC)
Innovation, Science and Economic Development Canada (ISED)
Patented Medicine Prices Review Board (PMPRB)
Privy Council Office (PCO)
Public Health Agency of Canada (PHAC)
Senate of Canada

Government institutions added through a communication report:

Prime Minister's Office (PMO)

Communication techniques

Communication techniques that have been used or are expected to be used in the course of the undertaking:

Written communication
Oral communication

Who are the lobbyists?

Senior Officers whose lobbying activities represent less than 20% of their Duties

Paul Petrelli, General Manager | No public offices held

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

Bobby Sutherland, Sr. Director, Government Affairs | No public offices held

Lobbyists in previous versions
Senior Officers whose lobbying activities represent less than 20% of their Duties
- Scott Spencer, Executive Director, Finance - Interim General Manager | No public offices held

Registration number: 959600-360912
View all registrations versions

Monthly Communication Reports

What oral and arranged communications have taken place?

What oral and arranged communications have taken place?
Date	DPOH, Position Title \| Government Institution	Subject Matters
2025-01-28	Stephen Ellis, Member of Parliament House of Commons	Aboriginal Affairs, Economic Development, Employment and Training, Health, Immigration, Industry, Intellectual Property, International Trade, Research and Development, Science and Technology
2024-12-09	Fatima Asghar, Policy Advisor Health Canada (HC)	Aboriginal Affairs, Health, Immigration, Industry, Research and Development, Science and Technology
2024-11-27	Katherine McAllister, Director of Parliamentary Affairs \| MP Jenica Atwin's Office, House of Commons	Aboriginal Affairs, Health, Immigration, Industry, Research and Development, Science and Technology
2024-09-24	Earl Dreeshan, Member of Parliament House of Commons	Economic Development, Health, Industry, Research and Development, Science and Technology
2024-09-24	Tom Kmiec, Member of Parliament House of Commons	Economic Development, Health, Industry, Research and Development, Science and Technology
2024-09-24	Valerie Bradford, Member of Parliament House of Commons	Economic Development, Health, Industry, Research and Development, Science and Technology
2024-09-24	Corey Tochor, Member of Parliament House of Commons	Economic Development, Health, Industry, Research and Development, Science and Technology
2024-09-23	Tony Baldinelli, Member of Parliament House of Commons	Economic Development, Health, Industry, Research and Development, Science and Technology
2024-09-23	Matt Jeneroux, Member of Parliament House of Commons	Economic Development, Health, Industry, Research and Development, Science and Technology
2024-07-29	Michelle Boudreau, Executive Director \| Office of Pharmaceutical Management Strategies, Health Canada (HC)	Health, Industry, Research and Development
2024-07-12	Deliah Bernard, Indigenous Affairs and Policy Advisor \| Operations and Outreach, Prime Minister's Office (PMO)	Aboriginal Affairs, Health
2024-07-11	Fatima Asghar, Policy Advisor Health Canada (HC)	Health, Industry, Research and Development
2024-07-03	Cyndi Jenkins, Chief of Staff to the Minister Health Canada (HC)	Health, Research and Development, Science and Technology
2024-05-28	Carol Hughes, Member of Parliament House of Commons	Aboriginal Affairs, Health
2024-05-28	Anthony Rota, Member of Parliament House of Commons	Aboriginal Affairs, Health
2024-05-27	Steven Sternthal, Director General Public Health Agency of Canada (PHAC)	Aboriginal Affairs, Health
2024-05-23	Isabelle Buchanan, Policy advisor Immigration, Refugees and Citizenship Canada (IRCC) Craig Shankar, Director General Immigration, Refugees and Citizenship Canada (IRCC)	Health, Immigration
2024-05-23	Blaine Calkins, Member of Parliament House of Commons Earl Dreeshan, Member of P House of Commons Stephen Ellis, Member of Parliament House of Commons Tom Kmiec, Member of Parliament House of Commons	Health, Intellectual Property, Research and Development, Science and Technology

View all monthly communication reports

Gilead Sciences Canada - Address & business activities

Address:

6925 Century Avenue, suite 400
Mississauga, ON L5N 7K2
Canada

Telephone number: 905-363-8008

Contact information in previous versions
- 6925 Century Avenue, suite 400
  Mississauga, ON L5N 7K2
  Canada
  
  Telephone number: 905-363-8008
  
  Fax number: 905-363-8049
- 6925 Century Avenue, suite 400
  Mississauga, ON L5N 7K2
  Canada
  
  Telephone number: 416-919-6379
- 6711 Mississauga Rd, suite 600
  Mississauga, ON L5N 2W3
  Canada
  
  Telephone number: 416-919-6379
- 6711 Mississauga Rd, suite 600
  Mississauga, ON L5N 2W3
  Canada
  
  Telephone number: 905-363-8001 Ext. 8001
- 6711 Mississauga Rd, suite 600
  Mississauga, ON L5N 2W3
  Canada
  
  Telephone number: 905-363-8008
  
  Fax number: 905-363-8019

Description of activities:
Gilead Sciences Canada Inc. is the Canadian affiliate of Gilead Sciences inc. Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet need. The company has a focus within the HIV, hepatitis, antiviral agents for pandemic response for COVID-19, inflammatory diseases, oncology and respiratory therapeutic areas.

Descriptions of the corporation's activity in previous versions:
- Gilead Sciences Canada Inc. is the Canadian affiliate of Gilead Sciences inc. Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet need. The company has a focus within the HiV, Hepatitis, Oncology and Respiratory therapeutic areas.

Date Modified:: 2025-04-30

Search and menus

Language selection

12-Month Lobbying Summary - In-house Corporation

Gilead Sciences Canada / Paul Petrelli, General Manager

Who is lobbying?

Gilead Sciences Canada (Address & business activities)

Received government funding or funding expected in current financial year

Business Relationships

Gilead Sciences Canada is a subsidiary of the following parent companies

Beneficiaries of the Lobbying Activity

What is being lobbied?

Subject Matter Details

Who is being lobbied?

Government Institutions

Government institutions added through a communication report:

Communication techniques

Who are the lobbyists?

Senior Officers whose lobbying activities represent less than 20% of their Duties

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

Senior Officers whose lobbying activities represent less than 20% of their Duties

What oral and arranged communications have taken place?

12-Month Lobbying Summary - In-house Corporation

Gilead Sciences Canada / Paul Petrelli, General Manager

Gilead Sciences Canada (Address & business activities)

Received government funding or funding expected in current financial year

Business Relationships

Gilead Sciences Canada is a subsidiary of the following parent companies

Beneficiaries of the Lobbying Activity

Subject Matter Details

Government Institutions

Government institutions added through a communication report:

Communication techniques

Senior Officers whose lobbying activities represent less than 20% of their Duties

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

Senior Officers whose lobbying activities represent less than 20% of their Duties

Gilead Sciences Canada - Address & business activities

Gilead Sciences Inc